Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Align Technology, Inc. (NASDAQ: ALGN) is a global medical device company best known for the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software. The ALGN news feed on Stock Titan aggregates company announcements, clinical product updates, financial disclosures, and professional education highlights directly relevant to investors and dental professionals.
Recent news shows Align focusing on digital orthodontics and restorative dentistry, with updates on innovations such as ClinCheck® Live Plan for automated Invisalign treatment planning, new features for iTero Digital Solutions, and expanded availability of Invisalign System options like mandibular advancement with occlusal blocks for Class II correction in growing patients. News items also cover Align’s participation in major dental congresses, including the Greater New York Dental Meeting, where the company showcases its Align™ Digital Platform and related tools.
Investors following ALGN news will see regular earnings announcements and outlook updates, including quarterly revenue, clear aligner volumes, imaging systems and CAD/CAM services performance, and commentary on geographic trends. SEC-related press releases, such as those tied to Form 8-K filings on financial results or leadership changes, also appear in the news flow.
Align’s communications further highlight research, education, and community programs, including its Annual Research Award Program for university-based dental research and partnerships with organizations like the Canadian Foundation for the Advancement of Orthodontics through Smiles4Canada. For users tracking ALGN, this news page offers a centralized view of product launches, clinical innovations, financial milestones, and corporate initiatives that shape the company’s role in digital dentistry.
Align Technology (NASDAQ: ALGN) has announced new iTero intraoral scanner innovations aimed at enhancing digital dentistry workflows. The company introduced three key products: the Align Oral Health Suite with comparison tools for assessments and reports, Invisalign Outcome Simulator Pro with multiple treatment simulations, and iTero Design Suite for in-practice 3D printing. GP practices using iTero scanners and Align Oral Health Suite saw 9% higher estimated monthly revenue compared to non-users. These innovations support patient education, treatment planning, and practice efficiency, and are expected to be available in Q4 2024.
Align Technology (Nasdaq: ALGN) has announced the availability of its Invisalign Palatal Expander System in Singapore. This innovative, removable device is designed for skeletal and dental expansion in growing patients, offering an alternative to traditional metal expanders. The system, now listed on the Singapore Medical Device Register as a class B medical device, is 3D printed and customized based on iTero intraoral scans.
Combined with Invisalign First aligners, it provides a complete early intervention treatment solution for Phase 1 orthodontic treatment. The system is already available in Australia, New Zealand, and Hong Kong, with plans to expand to other APAC markets in 2024. This launch reflects Align's commitment to advancing digital orthodontics and enhancing patient treatment experiences.
Align Technology (Nasdaq: ALGN) has announced the commercial availability of its Invisalign Palatal Expander System in Hong Kong. This innovative, direct 3D printed device offers an effective and removable alternative to traditional palatal expanders for skeletal and dental expansion in growing patients.
The system consists of a series of customized, removable devices designed using AI-driven orthodontic software based on iTero intraoral digital scans. When combined with Invisalign First aligners, it provides a complete early intervention treatment solution for Phase 1 orthodontic treatment, typically for patients aged 6-10.
The Invisalign Palatal Expander System is already available in Australia and New Zealand, with plans to expand to additional APAC markets in 2024, pending regulatory approvals.
Align Technology (Nasdaq: ALGN) has announced it will report its third quarter 2024 financial results on Wednesday, October 23, 2024, after market close. The results will be released at 4:00 p.m. ET and will be available on the company's Investor Relations website. A conference call to discuss the results will follow at 4:30 p.m. ET, which will also be accessible via webcast.
Align Technology is a global medical device company specializing in clear aligners, intraoral scanners, and CAD/CAM software for digital orthodontics and restorative dentistry. The company's product portfolio includes the Invisalign® System, iTero™ intraoral scanners, and exocad™ CAD/CAM software. Align has treated over 18.2 million patients with the Invisalign System and serves more than 266,000 doctor customers worldwide.
Align Technology (NASDAQ: ALGN) announced that the U.S. District Court for the Northern District of California has granted preliminary approval of a settlement to resolve shareholder derivative litigation pending since 2019. Under the settlement terms:
- Plaintiffs will dismiss lawsuits and release claims
- Align and defendants deny wrongdoing
- No monetary payments, except potential $575,000 in attorney's fees to plaintiffs' counsel, covered by insurance
The settlement includes corporate governance reforms to be maintained for at least 3 years, such as:
- Formalizing a management-level Disclosure Committee
- Adding a cybersecurity expert to the Audit Committee
- Enhancing board training and disclosures
- Expanding compliance and ethics roles
A final approval hearing is scheduled for February 4, 2025. Stockholders may object to the settlement by December 24, 2024.
Align Technology (Nasdaq: ALGN), a leading global medical device company, has announced its participation in an upcoming financial conference. The company, known for its Invisalign® System, iTero™ intraoral scanners, and exocad™ CAD/CAM software, will be presenting at Baird's 2024 Global Healthcare Conference on September 10, 2024, from 9:05 to 9:35 a.m. ET in New York, NY. John Morici, CFO, will be the speaker.
The presentation will be webcast live via Align's Investor Relations website, with an archived replay available for approximately three months. Align Technology has treated over 18.2 million patients with the Invisalign System and serves more than 266,000 doctor customers worldwide, targeting a 600 million consumer market opportunity.
Align Technology (Nasdaq: ALGN) has announced key leadership changes for its regional operations. David Carr, a medical technology industry veteran, joins as EVP and MD of the Asia Pacific region. Raj Pudipeddi, current EVP and MD of Asia Pacific and Chief Marketing Officer, will lead the Americas region while retaining his CMO role. Simon Beard continues to lead the EMEA region as EVP and MD.
These changes aim to strengthen Align's global leadership team, leveraging each executive's expertise in their respective markets. Carr brings over 25 years of management experience in healthcare and automotive industries, with a deep understanding of the Asia Pacific region. This restructuring is part of Align's strategy to enhance its position in the clear aligner and digital dentistry markets, serving over 266,000 doctors and targeting a 600 million consumer market opportunity worldwide.
Align Technology (NASDAQ: ALGN) has launched a pilot promotional program for Invisalign treatment on Costco.com in the U.S. Costco members can purchase an Invisalign treatment e-card and Essentials Bundle+ for $99.99, receiving a $400 discount off Invisalign treatment with participating providers. The bundle includes an aligner case, cleaning products, and accessories valued at $105.00.
This initiative aims to connect Costco members with Invisalign-trained dental practices, aligning with Align's priority to increase access to their innovative orthodontic solutions. Invisalign has treated over 18 million patients worldwide, including more than 5 million teenagers, offering a comfortable and effective alternative to traditional braces. Studies suggest Invisalign treatment is completed 5 months faster on average than fixed appliances.
Align Technology reported Q2'24 revenues of $1,028.5 million, up 3.1% sequentially and 2.6% YoY. The company achieved a diluted net income per share of $1.28, or $2.41 on a non-GAAP basis. Clear Aligner revenues were $831.7 million, up 1.8% sequentially but down 0.1% YoY, with volumes increasing 6.2% sequentially and 3.2% YoY. Imaging Systems and CAD/CAM Services revenues rose to $196.8 million, a 9.2% sequential and 16.1% YoY increase. Adverse foreign exchange impacts affected revenues and margins. Operating income was $147.0 million with a GAAP operating margin of 14.3% and non-GAAP operating margin of 22.3%. Align also announced a $31.1 million settlement regarding legal matters. Moreover, the company repurchased 0.6 million shares at an average price of $250.73. Looking forward, Align expects Q3'24 revenues between $980M and $1,000M and FY'24 revenue growth of 4%-6% YoY.
Align Technology (NASDAQ: ALGN) has introduced the iTero™ Design Suite, a new software innovation designed to boost practice efficiency and enhance patient experiences. This suite offers doctors an intuitive way to design for in-practice 3D printing of models, bite splints, and restorations, leveraging exocad™ CAD/CAM software.
The iTero Design Suite is now available through an early access program, with full availability expected later this year. It enhances the Align™ Digital Platform, providing seamless end-to-end workflows for dental professionals. The software is compatible with leading 3D printers and aims to shorten time to treatment through simplified design applications.